Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model

J Antimicrob Chemother. 2002 Feb;49(2):331-5. doi: 10.1093/jac/49.2.331.

Abstract

A sepsis BALB/c mice model was used to investigate the relationship between mortality and the bacteraemic profile produced by a serotype 6B Streptococcus pneumoniae clinical isolate (MIC/MBC of amoxicillin 4/4 mg/L and of cefotaxime 2/4 mg/L). Animals were treated subcutaneously with doses of amoxicillin or cefotaxime ranging from 6.25 to 50 mg/kg tds for 48 h, starting 1 h after intraperitoneal inoculation (2 x 10(7) cfu/mouse). Blood cultures were carried out daily over 15 days. A survival rate of 100% was obtained with amoxicillin 25 mg/kg and of 60% with cefotaxime 50 mg/kg. A statistically significant (P = 0.012) relationship was found between the maximum cfu/mL in blood and mortality. A maximum log cfu/mL of 6.5 was associated with an 84% probability of death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Bacteremia / mortality
  • Colony Count, Microbial
  • Disease Models, Animal*
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical / statistics & numerical data
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests / statistics & numerical data
  • Pneumococcal Infections / drug therapy*
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / mortality
  • Sepsis / drug therapy*
  • Sepsis / microbiology
  • Sepsis / mortality
  • beta-Lactams

Substances

  • Anti-Bacterial Agents
  • beta-Lactams